Stelara (Ustekinumab) now available for young adults
The biologic treatment Stelara (Ustekinumab) is now available for the treatment of moderate-to-severe plaque psoriasis in adolescents age 12 years and older who have not responded to or are intolerant to other systemic therapies or phototherapies. Psoriasis is an inflammatory skin condition affecting about 2% of the population, which is characterised by red and scaly …
Stelara (Ustekinumab) now available for young adults Read More »